| Day 1, Thursday, May 15th | |
|---|---|
| 08:00-09:30 | Industry-supported Pre-COMy Symposium |
| 09:30-09:40 | Technical Break |
| 09:40-09:50 | COMy 2025 kick-off: Welcome by the Congress Co-Chairs |
| 09:50-11:20 | Session 1: Advances in biology I |
| Moderators: Eileen Boyle, USA; Paola Neri, Canada | |
| 09:50-10:05 | WGS: Samur Mehmet, USA |
| 10:05-10:20 | Clonal diversity: Joaquín Martínez López, Spain |
| 10:20-10:35 | Circulating tumor cells and DNA: Andrew Spencer, Australia |
| 10:35-10:50 | sBCMA and non-T cell factors: Marc Raab, Germany |
| 10:50-11:05 | Mass spectrometry: Noemi Puig, Spain |
| 11:05-11:20 | Discussion: All session faculty and Nizar Bahlis, Canada |
| 11:20-11:40 | Coffee Break |
| 11:40-13:10 | Session 2: How do I assess? |
| Moderators: Joan Bladé, Spain; Heinz Ludwig, Austria | |
| 11:40-11:55 | AI individualized risk classifier: Francesco Maura, USA |
| 11:55-12:10 | Disease response: Shaji Kumar, USA |
| 12:10-12:25 | Imaging: Elena Zamagni, Italy |
| 12:25-12:40 | Disease risk: Jill Corre, France |
| 12:40-12:55 | From detection to decision: the status of MGUS screening: Sigurdur Kristinsson, Iceland |
| 12:55-13:10 | Discussion: All session faculty and Paola Neri, Canada, Enrique Ocio, Spain |
| 13:10-13:40 | Lunch Break |
| 13:40-15:10 | Industry-supported Lunch Symposium |
| 15:10-15:20 | Technical Break |
| 15:20-16:20 | Session 3: Advances in biology II |
| Moderator: Malin Hultcrantz, USA | |
| 15:20-15:35 | Protein degraders: Robert Orlowski, USA |
| 15:35-15:50 | The unanswered science of myeloma: Keith Stewart, Canada |
| 15:50-16:05 | Next generation CAR constructs: Noopur Raje, USA |
| 16:05-16:20 | Discussion: All session faculty and Faith Davies, USA, Michael O’Dwyer, Ireland |
| 16:20-16:40 | Coffee Break |
| 16:40-18:10 | Industry-supported Afternoon Symposium |
| 18:10-18:20 | Technical Break |
| 18:20-19:00 | Session 4: Plenary lectures I |
| Moderators: Gareth Morgan, USA; Charlotte Pawlyn, UK | |
| 18:20-18:40 | From Thalidomide to CelMods: a clinical journey: Meletios Dimopoulos, Greece |
| 18:40-19:00 | Genomics to personalize therapy: Nikhil Munshi, USA |
| 19:00-19:30 | Session 5: The COMy Debate: Treatment of smoldering myeloma |
| Moderator: Philippe Moreau, France | |
| 19:00-19:10 | YES: Irene Ghobrial, USA |
| 19:10-19:20 | NO: Hervé Avet-Loiseau, France |
| 19:20-19:30 | Discussion: All session faculty and Claudio Cerchione, Italy, María-Victoria Mateos, Spain, Karthik Ramasamy, UK |
| Day 2, Friday, May 16th | |
|---|---|
| 07:30-08:15 | Industry-supported Breakfast Symposium |
| 08:15-08:25 | Technical Break |
| 08:25-09:35 | Session 6: How do I treat? Part I |
| Moderators: Thierry Facon, France; Francesca Gay, Italy | |
| 08:25-08:40 | Transplant-eligible patients: Aurore Perrot, France |
| 08:40-08:55 | Elderly patients: Sonja Zweegman, Netherlands |
| 08:55-09:10 | High-risk disease: Cyrille Touzeau, France |
| 09:10-09:25 | Amyloidosis: Suzanne Lentzsch, USA |
| 09:25-09:35 | Discussion: All session faculty and Martin Kaiser, UK, Alessandra Larocca, Italy |
| 09:35-09:55 | Coffee Break |
| 09:55-11:25 | Industry-supported Morning Symposium |
| 11:25-11:35 | Technical Break |
| 11:35-12:20 | Session 7: IMS Session |
| Moderators: | |
| 11:35-11:50 | TBA |
| 11:50-12:05 | TBA |
| 12:05-12:20 | Discussion |
| 12:20-12:50 | Lunch Break |
| 12:50-14:20 | Industry-supported Lunch Symposium |
| 14:20-14:30 | Technical Break |
| 14:30-15:15 | Session 8: Next generation therapies |
| Moderators: | |
| 14:30-14:45 | TBA |
| 14:45-15:00 | TBA |
| 15:00-15:15 | TBA |
| 15:15-16:00 | Session 9: Plenary lectures II |
| Moderators: Bertrand Arnulf, France; Yael Cohen, Israel | |
| 15:15-15:30 | The Academic CAR-T cells experience: Carlos Fernández de Larrea, Spain |
| 15:30-15:45 | Antigenic escape with T cell redirecting immunotherapies: Nizar Bahlis, Canada |
| 15:45-16:00 | Discussion: All session faculty and Javier de la Rubia, Spain, Doris Hansen, USA |
| 16:00-16:20 | Coffee Break |
| 16:20-17:50 | Industry-supported Afternoon Symposium |
| 17:50-18:00 | Technical Break |
| 18:00-19:00 | Session 10: Treatment of relapsed/refractory disease |
| Moderators: Roman Hajek, Czech Republic; Thomas Martin, USA | |
| 18:00-18:15 | Management of patients after 1 prior line of therapy: María-Victoria Mateos, Spain |
| 18:15-18:30 | Management of patients triple class refractory with CAR-T cells: Paula Rodríguez-Otero, Spain |
| 18:30-18:45 | Management of patients triple class refractory with bispecifics: Saad Usmani, USA |
| 18:45-19:00 | Discussion: All session faculty and Hermann Einsele, Germany; Cesar Rodriguez, USA |
| 19:00-19:30 | COMy Award Ceremony |
| Presented by the Congress Co-Chairs | |
| Day 3, Saturday, May 17th | |
|---|---|
| 08:15-08:30 | Good Morning Coffee |
| 08:30-10:20 | Session 11: The ideal trial on the road to achieve the best outcome for patients |
| Moderators: Jean-Luc Harousseau, France; Jesús San Miguel, Spain | |
| 08:30-08:45 | A US perspective: Sagar Lonial, USA |
| 08:45-09:00 | EMN perspective: Pieter Sonneveld, Netherlands |
| 09:00-09:15 | UK perspective: Kwee Yong, UK |
| 09:15-09:30 | IFM perspective in young patients: Philippe Moreau, France |
| 09:30-09:45 | IFM and Spanish perspective in elderly patients: Salomon Manier, France |
| 09:45-10:00 | German perspective: Hartmut Goldschmidt, Germany |
| 10:00-10:20 | Discussion: All session faculty |
| 10:20-10:35 | Coffee Break continued … |
| 10:35-11:50 | Industry-supported Morning Symposium |
| 11:50-12:00 | Technical Break |
| 12:00-12:45 | Session 12: Hot topics |
| Moderators: Graham Jackson, UK; Noor Moukalled, Lebanon | |
| 12:00-12:15 | Maintenance therapy after ASCT: Xavier Leleu, France |
| 12:15-12:30 | Fixed duration vs. continuous maintenance therapy: Paul Richardson, USA |
| 12:30-12:45 | Discussion: All session faculty and Malin Hultcrantz, USA; Roberto Mina, Italy |
| 12:45-13:15 | Lunch Break |
| 13:15-14:45 | Industry-supported Lunch Symposium |
| 14:45-14:55 | Technical Break |
| 14:55-16:10 | Session 13: How do I treat? Part II |
| Moderators: Michel Delforge, Belgium; Albert Oriol, Spain | |
| 14:55-15:10 | Extra-medullary plasmacytoma: Meral Beksaç, Turkey |
| 15:10-15:25 | Patients under dialysis: Florent Malard, France |
| 15:25-15:40 | Bone disease: Evangelos Terpos, Greece |
| 15:40-15:55 | Waldenstrom disease: Steven Treon, USA |
| 15:55-16:10 | Discussion: All session faculty and Laura Rosiñol Dachs, Spain, Rafat Abonour, USA |
| 16:10-16:30 | Coffee Break |
| 16:30-18:00 | Industry-supported Afternoon Symposium |
| 18:00-18:10 | Technical Break |
| 18:10-19:15 | Session 14: Keynote lectures |
| Moderators: Vania Hungria, Brazil; Lalit Kumar, India | |
| 18:10-18:35 | Affordable therapy algorithm: Vincent Rajkumar, USA |
| 18:35-19:00 | The future of myeloma therapy: Kenneth Anderson, USA |
| 19:00-19:15 | Discussion: All session faculty |
| 19:15-19:30 | COMy In-Person Conclusions by the Congress Co-Chairs |
| Day 4, Sunday, May 18th – ONLINE ONLY | |
|---|---|
| Multiple Myeloma communications I | |
| TBA | |
| Discussion | |
| Virtual Industry Symposium | |
| Multiple Myeloma communications II | |
| TBA | |
| Discussion | |
| Virtual Industry Symposium | |
| Final Panel Discussion and Conclusion | |
